Hypomethylating agents (HMAs) effect on myelodysplastic/myeloproliferative neoplasm unclassifiable (MDS/MPN-U): single institution experience.
Aref A Al-KaliAhmed Kamel Abou HusseinMirinal S PatnaikDarci ZblewskiNaseema GangatShahrukh HashmiMichelle ElliottWilliam Joseph HoganMark R LitzowPublished in: Leukemia & lymphoma (2018)